Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06736717 |
| Title | Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer (PANCONVA) |
| Acronym | PANCONVA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | University of Kansas Medical Center |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| The University of Kansas Cancer Center, Westwood Campus | RECRUITING | Kansas City | Kansas | 66205 | United States | Details |